ATLASATLAS fair value
ATLAS has no fair value for this stock today.
SOPHiA GENETICS SA (SOPH)
SOPHiA GENETICS SA stock price today, ATLAS forecast and fair value
Healthcare · Health Information Services · NASDAQ
$7.54▲ +0.27%
Prices as of Oct 27, 2026 · USD
Chance of rising in 1 month
47%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on SOPHiA GENETICS SA in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On SOPHiA GENETICS SA
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives SOPHiA GENETICS SA a 47% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between $6.61 and $8.37; in 9 out of 10, between $5.35 and $10.33. Estimated annual volatility is 65%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- $687M
- 52-week high
- $8.98
- 52-week low
- $3.83
- Revenue (12 months)
- $86.2M
- Revenue growth (YoY)
- +18.6%
- Gross margin
- 67.4%
- Operating margin
- -91.8%
- Net margin
- -102.2%
- Return on equity
- -101.2%
- Free cash flow (12 months)
- $-25.7M
- Beta
- 0.98
What this means
ATLAS does not publish a fair value for SOPH right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks SOPH has traded between $3.83 and $8.98. Today it is 16.0% below that high and 97% above its low.
On the business: revenue grew 18.6% year over year; net margin is 102.2%.
Its beta is 0.98: it moves roughly in line with the market.
About the company
SOPHiA GENETICS SA Ordinary Shares is the equity of SOPHiA GENETICS, a healthcare technology company focused on data-driven medicine and life sciences research.
Want to see everything about SOPHiA GENETICS SA?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does SOPHiA GENETICS SA do?
SOPHiA GENETICS SA Ordinary Shares is the equity of SOPHiA GENETICS, a healthcare technology company focused on data-driven medicine and life sciences research.
What is the chance SOPH goes up next month?
47%: close to a coin flip. In half of the simulated outcomes, SOPH ends the month between $6.61 and $8.37.
How big is SOPHiA GENETICS SA and what is its P/E ratio?
SOPHiA GENETICS SA's market capitalization is $687M. We do not show a P/E because it has no positive earnings to base one on.
How volatile is SOPH?
ATLAS estimates annual volatility at 65%. In a typical month, half of the outcomes end between $6.61 and $8.37.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer